1-4 of 4
Rachel A. Carter
Close
Sort by
Journal Articles

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

Morgan Hakki, Stanley R. Riddell, Jan Storek, Rachel A. Carter, Terry Stevens-Ayers, Patrick Sudour, Kristen White, Lawrence Corey, Michael Boeckh
Journal: Blood
Blood (2003) 102 (8): 3060–3067.
https://doi.org/10.1182/blood-2002-11-3472
Published: 2003
Journal Articles

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

Clinical Trials & Observations
Takahiro Fukuda, Michael Boeckh, Rachel A. Carter, Brenda M. Sandmaier, Michael B. Maris, David G. Maloney, Paul J. Martin, Rainer F. Storb, Kieren A. Marr
Journal: Blood
Blood (2003) 102 (3): 827–833.
https://doi.org/10.1182/blood-2003-02-0456
Published: 2003
Journal Articles

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

Clinical Trials & Observations
Kieren A. Marr, Rachel A. Carter, Michael Boeckh, Paul Martin, Lawrence Corey
Journal: Blood
Blood (2002) 100 (13): 4358–4366.
https://doi.org/10.1182/blood-2002-05-1496
Published: 2002
Journal Articles

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

Clinical Trials & Observations
Christian Junghanss, Michael Boeckh, Rachel A. Carter, Brenda M. Sandmaier, Michael B. Maris, David G. Maloney, Thomas Chauncey, Peter A. McSweeney, Marie-Térèse Little, Lawrence Corey, Rainer Storb
Journal: Blood
Blood (2002) 99 (6): 1978–1985.
https://doi.org/10.1182/blood.V99.6.1978
Published: 2002